Image

ALS Spinal Cord Gray and White Matter Study

ALS Spinal Cord Gray and White Matter Study

Recruiting
18-99 years
All
Phase N/A

Powered by AI

Overview

This study aims to measure in vivo the spinal cord gray and white matter in patients with Amyotrophic Lateral Sclerosis and healthy persons that match the patients' age and sex using rAMIRA imaging, a novel Magnetic Resonance Imaging (MRI) method. Patients and healthy control persons prospectively undergo MRI examinations, clinical examinations including assessments of disability, and tests of muscle force using hand held dynamometry. Serum markers of neuro-axonal injury are also assessed.

Examinations for patients and healthy control persons are scheduled every six months over a time span of two years.

Eligibility

Inclusion Criteria (patients):

  1. 18 years or older
  2. neurologist-confirmed possible, probable or definite ALS acc. to El Escorial criteria
  3. at baseline: able to lie in an MRI scanner for one hour

Exclusion Criteria (patients):

  1. active other neurological or neuromuscular condition explaining the symptoms or a significant part of it
  2. other neurological or neuromuscular conditions interfering with the examinations
  3. severe cervical spinal stenosis or other relevant disease of the spine or spinal cord that may interfere with study procedures or that may impact the cord segments imaged in this study
  4. other severe chronic disease
  5. pregnancy
  6. general contraindications against MRI scanning (e.g. metal implants, pacemakers)
  7. not able to read the patient information due to language barriers (patient information in English and French may be provided)
  8. major cognitive deficit impacting the ability to read and understand the patient information and/or to follow the instructions of the study personnel

Inclusion criteria (healthy control persons):

  1. 18 years or older
  2. able to lie in MRI scanner for one hour

Exclusion criteria (healthy control persons):

  1. neurological or neuromuscular conditions
  2. other severe chronic disease
  3. pregnancy
  4. general contraindications against MRI scanning (e.g. metal implants, pacemakers)
  5. relevant cervical spinal canal stenosis or other relevant disease of the spine or spinal cord that may interfere with study procedures or that may impact the cord segments imaged in this study
  6. not able to read the patient information due to language barriers (patient information in English and French may be provided)

Inclusion criteria (patients with Motor Neuron Diseases other than ALS):

  1. 18 years or older
  2. neurologist-confirmed Motor Neuron Disease (not ALS)
  3. able to lie in MRI scanner for one hour

Exclusion criteria (patients with Motor Neuron Diseases other than ALS):

  1. other severe neurologic disease
  2. other severe chronic disease
  3. pregnancy
  4. general contraindications against MRI scanning (e.g. metal implants, pacemakers)
  5. relevant cervical spinal canal stenosis or other relevant disease of the spine or spinal cord that may interfere with study procedures or that may impact the cord segments imaged in this study
  6. not able to read the patient information due to language barriers (patient information in English and French may be provided)

Study details
    Amyotrophic Lateral Sclerosis

NCT05764434

University Hospital, Basel, Switzerland

26 January 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.